US 12,335,692 B2
Implantable tinnitus therapy
Thomas Leroux, Macquarie University (AU); and Olivier Le Caharec, Macquarie University (AU)
Assigned to Cochlear Limited, Macquarie University (AU)
Appl. No. 17/798,782
Filed by Cochlear Limited, Macquarie University (AU)
PCT Filed Jan. 20, 2021, PCT No. PCT/IB2021/050426
§ 371(c)(1), (2) Date Aug. 10, 2022,
PCT Pub. No. WO2021/165759, PCT Pub. Date Aug. 26, 2021.
Claims priority of provisional application 62/979,501, filed on Feb. 21, 2020.
Prior Publication US 2023/0110745 A1, Apr. 13, 2023
Int. Cl. H04R 25/00 (2006.01); A61N 1/02 (2006.01); A61N 1/36 (2006.01)
CPC H04R 25/75 (2013.01) [A61N 1/025 (2013.01); A61N 1/36036 (2017.08); A61N 1/36132 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method, comprising:
detecting signals at one or more implantable sensors configured to be implanted in a recipient, wherein the signals comprise one or more body noises of the recipient;
generating, based on the one or more body noises, one or more body noise classifications;
generating tinnitus therapy signals based on the one or more body noise classifications; and
delivering the tinnitus therapy signals to the recipient.